Tumor mutational burden is not predictive of cytotoxic chemotherapy response

BACKGROUND: High tumor mutational burden (TMB) predicts checkpoint blockade responsiveness, although the association with outcomes may be nuanced in certain tissue contexts. The correlation between TMB and cytotoxic chemotherapy sensitivity is unknown. This study evaluated the relationship between T...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikanjam, Mina, Riviere, Paul, Goodman, Aaron, Barkauskas, Donald A., Frampton, Garrett, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458654/
https://www.ncbi.nlm.nih.gov/pubmed/32923144
http://dx.doi.org/10.1080/2162402X.2020.1781997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458654/
https://www.ncbi.nlm.nih.gov/pubmed/32923144
http://dx.doi.org/10.1080/2162402X.2020.1781997

Ejemplares similares